Loading...
India's metformin imports from URUGUAY total $8 across 2 shipments from 1 foreign suppliers. MEGA LABS S.A leads with $8 in import value; the top 5 suppliers together control 100.0% of this origin. Leading Indian buyers include AZIDUS LABORATORIES LIMITED. This corridor reflects India's pharmaceutical import demand for metformin — a concentrated sourcing relationship with select suppliers from URUGUAY.
MEGA LABS S.A is the leading Metformin supplier from URUGUAY to India, with import value of $8 across 2 shipments. The top 5 suppliers — MEGA LABS S.A — collectively account for 100.0% of total import value from this origin.
Ranked by import value (USD) · Indian Customs (DGFT) data
| # | Supplier | Value (USD) | Shipments | Share |
|---|---|---|---|---|
| 1 | MEGA LABS S.A | $8 | 2 | 100.0% |
Ranked by import value (USD)
| # | Buyer | Value (USD) | Shipments | Share |
|---|---|---|---|---|
| 1 | AZIDUS LABORATORIES LIMITED | $8 | 2 | 100.0% |
URUGUAY → India trade corridor intelligence
The Uruguay to India shipping corridor is currently stable, with no significant port congestion reported at major Indian ports such as Jawaharlal Nehru Port (JNPT), Chennai, and Mundra. Freight rates have remained consistent over the past year, and the exchange rate between the Indian Rupee (INR) and the Uruguayan Peso remains favorable for trade. No significant disruptions have been reported in the shipping routes, ensuring reliable delivery times for Metformin formulations.
The Production Linked Incentive (PLI) scheme introduced by the Indian government aims to boost domestic manufacturing and reduce import dependency. While this policy encourages local production, it does not specifically target finished pharmaceutical formulations like Metformin. Therefore, imports from Uruguay continue to play a role in supplementing domestic supply, especially for specialized formulations. Import substitution policies are being evaluated, but no significant changes have been implemented that would impact the import of Metformin formulations from Uruguay.
India and Uruguay have established a cooperative trade relationship, with agreements in place to facilitate pharmaceutical trade. These agreements include mutual recognition of Good Manufacturing Practices (GMP), which simplifies the import process for Uruguayan pharmaceutical products. Discussions regarding a Free Trade Agreement (FTA) are ongoing, aiming to further enhance trade relations and address any existing barriers. These bilateral efforts are expected to strengthen the pharmaceutical trade corridor between the two countries.
The estimated landed cost for importing Metformin formulations from Uruguay to India includes the following components:
For a shipment of 100 kilograms, the estimated landed cost would be calculated as follows:
This estimate provides a general idea of the costs involved in importing Metformin formulations from Uruguay to India. Actual costs may vary based on specific agreements, shipping methods, and other factors.
CDSCO registration, import licensing, and quality testing requirements
To import finished pharmaceutical formulations containing Metformin into India, the foreign manufacturer must obtain an Import Registration Certificate and an Import License from the Central Drugs Standard Control Organization (CDSCO). The application process involves submitting Form 40/41 to CDSCO, along with necessary documents such as the Certificate of Pharmaceutical Product (CoPP), Good Manufacturing Practice (GMP) certificate, and stability data. The timeline for obtaining these approvals can vary, but it typically ranges from several months to over a year, depending on the completeness of the application and the regulatory review process. For Metformin formulations under HS Code 30049099, specific requirements include compliance with the Drugs and Cosmetics Act, 1940, and adherence to the Drugs and Cosmetics Rules, 1945. The manufacturer must also ensure that the product meets the quality standards set by the Indian Pharmacopoeia. Additionally, a No Objection Certificate (NOC) from the Ministry of Health and Family Welfare may be required, especially if the product is intended for sale in Special Economic Zones (SEZs) or for export purposes. The registration process involves a thorough evaluation of the product's safety, efficacy, and quality, and may include inspections of the manufacturing facility. It's essential for the foreign manufacturer to engage with CDSCO early in the process to understand all requirements and to facilitate a smoother approval timeline.
Imported Metformin formulations under HS Code 30049099 must undergo quality testing at CDSCO-approved laboratories in India. Each batch requires a Certificate of Analysis (CoA) confirming compliance with the Indian Pharmacopoeia standards. Stability data, particularly for ICH Zone IV conditions, must be provided to demonstrate the product's shelf-life and storage requirements. Upon arrival at Indian ports, customs drug inspectors conduct inspections to verify the authenticity and quality of the imported products. This process includes sampling and testing to ensure that the formulations meet the prescribed standards. If a batch fails to meet the required standards, it may be rejected, leading to potential delays, re-exportation, or destruction of the product. Therefore, it's crucial for the foreign manufacturer to ensure that all quality documentation is accurate and that the product consistently meets the required specifications.
Between 2024 and 2026, the CDSCO has implemented stricter regulations for the import of pharmaceutical products, including finished formulations containing Metformin. The introduction of the Production Linked Incentive (PLI) scheme has incentivized domestic manufacturing, potentially affecting the volume of imports. Additionally, bilateral agreements between India and Uruguay have been established to facilitate trade, including mutual recognition of Good Manufacturing Practices (GMP), which may streamline the import process for Uruguayan manufacturers. These developments aim to enhance the quality and safety of imported pharmaceuticals and encourage domestic production.
Market demand, customs duty structure, and competitive landscape · Import duty: 17.10%
India imports finished Metformin formulations to meet the demand for patented and branded products, as well as specific dosage forms not produced domestically. The domestic capacity for Metformin production is substantial; however, certain specialized formulations or higher-quality products may still be sourced from international markets. The market size for Metformin in India is significant, driven by the high prevalence of diabetes and the need for effective management of the condition. Imports play a role in supplementing domestic production to ensure a diverse and high-quality supply of Metformin formulations.
The Basic Customs Duty (BCD) for Metformin formulations under HS Code 30049099 is 10%. An additional Social Welfare Surcharge (SWS) of 10% is applied, resulting in a total duty of 20%. The Goods and Services Tax (GST) at 12% is applicable on the landed value of the product. There are no additional duties such as the Agriculture Infrastructure and Development Cess (AIDC) or Health Cess for this product category. Anti-dumping duties are not currently imposed on Metformin formulations under this HS Code. Exemptions or concessional rates are not available for imports from Uruguay. Therefore, the total landed duty percentage for Metformin formulations imported from Uruguay is approximately 32.4%.
Uruguay's pharmaceutical industry is known for producing high-quality Metformin formulations, which are competitive in the Indian market. The country's adherence to international quality standards and the availability of specialized dosage forms provide a competitive advantage. While other suppliers such as China, Germany, and the United States also export Metformin formulations to India, Uruguay's focus on quality and specific formulations not readily available from other sources makes it a valuable partner. Uruguay's share in the Indian Metformin import market is growing, reflecting the increasing recognition of its products' quality and reliability.
Import rationale, competitive comparison, supply chain risk, and procurement strategy
India imports Metformin formulations from Uruguay due to the country's reputation for producing high-quality pharmaceutical products that meet international standards. Urugu
Answers based on Indian Customs (DGFT) import records compiled by TransData Nexus
The top Metformin suppliers from URUGUAY to India include MEGA LABS S.A. The leading supplier is MEGA LABS S.A with import value of $8 USD across 2 shipments. India imported Metformin worth $8 USD from URUGUAY in total across 2 shipments.
India imported Metformin worth $8 USD from URUGUAY across 2 shipments. Data is from Indian Customs (DGFT) records. Values are in USD.
The main Indian buyers of Metformin sourced from URUGUAY include AZIDUS LABORATORIES LIMITED. The largest buyer is AZIDUS LABORATORIES LIMITED with $8 in imports across 2 shipments.
The total value of Metformin imports from URUGUAY to India is $8 USD, across 2 shipments and 1 foreign suppliers. Data source: Indian Customs (DGFT).
Data sourced from Indian Customs (DGFT) records. Verify regulatory and trade status with the agencies above.
Pharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormareAll trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
2 Verified Shipments
1 suppliers, 1 buyers tracked
Expert-Reviewed
By pharmaceutical trade specialists